Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance
出版年份 2021 全文链接
标题
Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance
作者
关键词
Ovarian cancer, Immunotherapy, Wnt/β-catenin signaling, Immune checkpoint blockade therapy, Tumor microenvironment
出版物
GYNECOLOGIC ONCOLOGY
Volume 164, Issue 1, Pages 170-180
出版商
Elsevier BV
发表日期
2021-11-26
DOI
10.1016/j.ygyno.2021.09.026
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DKN-01 in combination with pembrolizumab in patients with advanced gastroesophageal adenocarcinoma (GEA): Tumoral DKK1 expression as a predictor of response and survival.
- (2020) Samuel J. Klempner et al. JOURNAL OF CLINICAL ONCOLOGY
- B cells are associated with survival and immunotherapy response in sarcoma
- (2020) Florent Petitprez et al. NATURE
- Identification of CXCR4 and CXCL10 as Potential Predictive Biomarkers in Triple Negative Breast Cancer (TNBC)
- (2020) Tian Chuan et al. MEDICAL SCIENCE MONITOR
- Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer
- (2020) Ilaria Betella et al. GYNECOLOGIC ONCOLOGY
- Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment
- (2020) Whitney N. Goldsberry et al. Cancers
- 742P Activation of the WNT signaling pathway correlates with innate resistance to immune checkpoint therapies in clear cell renal cell carcinoma
- (2020) X. Sheng et al. ANNALS OF ONCOLOGY
- Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy
- (2020) J.A. Wall et al. GYNECOLOGIC ONCOLOGY
- mDKN-01, a Novel Anti-DKK1 Monoclonal Antibody, Enhances Innate Immune Responses in the Tumor Microenvironment
- (2020) Michael S. Haas et al. MOLECULAR CANCER RESEARCH
- WNT/β-catenin pathway activation correlates with immune exclusion across human cancers
- (2019) Jason J. Luke et al. CLINICAL CANCER RESEARCH
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments
- (2019) Shreya Raghavan et al. Journal for ImmunoTherapy of Cancer
- PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers
- (2019) Zheng Zhong et al. ONCOGENE
- WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment
- (2019) Xin Li et al. Frontiers in Immunology
- MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway
- (2019) Wei Yang et al. ONCOGENE
- Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
- (2019) Teeuwssen et al. Journal of Clinical Medicine
- Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
- (2018) Thomas Duhen et al. Nature Communications
- Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
- (2018) Jhajaira M. Araujo et al. Scientific Reports
- A phase II study of tumor-infiltrating lymphocyte therapy for human papillomavirus-associated epithelial cancers
- (2018) Sanja Stevanovic et al. CLINICAL CANCER RESEARCH
- The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities
- (2017) Nicole J. Flynn et al. Targeted Oncology
- Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth
- (2017) Taylor B. Turner et al. Oncotarget
- CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
- (2016) Holger Bronger et al. BRITISH JOURNAL OF CANCER
- A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
- (2016) Anne Montfort et al. CLINICAL CANCER RESEARCH
- CKAP4 is a Dickkopf1 receptor and is involved in tumor progression
- (2016) Hirokazu Kimura et al. JOURNAL OF CLINICAL INVESTIGATION
- Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer
- (2016) Lucia D’Amico et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer
- (2016) Ellen Stelloo et al. Oncotarget
- The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
- (2015) Seiji Mabuchi et al. GYNECOLOGIC ONCOLOGY
- Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients
- (2015) Xin Wei et al. TUMOR BIOLOGY
- Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration
- (2015) Timothy J. Zumwalt et al. Oncotarget
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer
- (2014) Lubomir Bodnar et al. Journal of Ovarian Research
- Tumor-Associated Macrophages Contribute to Tumor Progression in Ovarian Cancer
- (2014) Emily K. Colvin Frontiers in Oncology
- CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27- Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer
- (2012) J. S. Nielsen et al. CLINICAL CANCER RESEARCH
- Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients
- (2012) Balázs Győrffy et al. ENDOCRINE-RELATED CANCER
- IFN- in the Treatment of Melanoma
- (2012) A. A. Tarhini et al. JOURNAL OF IMMUNOLOGY
- WNT/β-Catenin-Signaling Pathway Stimulates the Proliferation of Cultured Adult Human Sertoli Cells via Upregulation of C-myc Expression
- (2012) Yi Li et al. Reproductive Sciences
- MHC Class I-Presented Tumor Antigens Identified in Ovarian Cancer by Immunoproteomic Analysis Are Targets for T-Cell Responses against Breast and Ovarian Cancer
- (2011) M. A. Morse et al. CLINICAL CANCER RESEARCH
- The emerging role of CXCL10 in cancer (Review)
- (2011) MINGLI LIU et al. Oncology Letters
- Ovarian cancer creates a suppressive microenvironment to escape immune elimination
- (2010) Refika Yigit et al. GYNECOLOGIC ONCOLOGY
- HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma
- (2008) L. Y. Han et al. CLINICAL CANCER RESEARCH
- The impact of T-cell immunity on ovarian cancer outcomes
- (2008) Brad H. Nelson IMMUNOLOGICAL REVIEWS
- HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance
- (2008) M Campoli et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More